PSYBF
PsyBio Therapeutics Corp.
Set alert
0.00 USD 0.00 0.00%
0.005 Day range 0.005
0.00001 52-week range 0.005
- YTD
- 0.00%
- 1 year
- -90.00%
- Open
- 0.005
- Prev close
- 0.00001
- Mkt cap
- 1.27K
- Vol
- 8.00K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.005
- High
- 0.005
Financial health
Altman Z-Score
-154.16 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.6×
FY 2016 5y median -1.5× FY 2022
P/S 0.0×
FY 2016 5y median 0.0× FY 2022
P/B -1.9×
FY 2016 5y median 0.0× FY 2022
P/FCF -0.9×
FY 2016 5y median -2.5× FY 2022
EV/EBITDA -0.7×
FY 2016 5y median -1.0× FY 2022
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2022
FCF Yield -116.4%
FY 2016 5y median -9.1% FY 2022
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2022
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2022
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2022
ROE 307.1%
FY 2016 5y median -12.6% FY 2022
ROIC 298.0%
FY 2016 5y median -13.9% FY 2022
ROA -1251.6%
FY 2016 5y median -274.9% FY 2022
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2022
Operating Income 52.0%
FY 2016 FY 2022
EPS (diluted) 58.0%
FY 2016 FY 2022
Free Cash Flow 50.5%
FY 2016 FY 2022
Financial Health
Current Ratio 0.1×
FY 2016 5y median 3.8× FY 2022
Quick Ratio 0.1×
FY 2016 5y median 3.8× FY 2022
Debt / Equity -0.1×
FY 2016 5y median 0.0× FY 2022
Net Debt / EBITDA -0.0×
FY 2016 5y median -0.0× FY 2022
Interest Coverage -206×
FY 2016 5y median 0.0× FY 2022
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2022
Annual · latest fiscal year ends 2022-12-31